Selective Inhibitors of FKBP51 Employ Conformational Selection of Dynamic Invisible States.

The recently discovered SAFit class of inhibitors against the Hsp90 co-chaperone FKBP51 show greater than 10 000-fold selectivity over its closely related paralogue FKBP52. However, the mechanism underlying this selectivity remained unknown. By combining NMR spectroscopy, biophysical and computational methods with mutational analysis, we show that the SAFit molecules bind to a transient pocket in FKBP51. This represents a weakly populated conformation resembling the inhibitor-bound state of FKBP51, suggesting conformational selection rather than induced fit as the major binding mechanism. The inhibitor-bound conformation of FKBP51 is stabilized by an allosteric network of residues located away from the inhibitor-binding site. These residues stabilize the Phe67 side chain in a dynamic outward conformation and are distinct in FKBP52, thus rationalizing the basis for the selectivity of SAFit inhibitors. Our results represent a paradigm for the selective inhibition of transient binding pockets.

[1]  Maria J. Pereira,et al.  FKBP5 expression in human adipose tissue: potential role in glucose and lipid metabolism, adipogenesis and type 2 diabetes , 2018, Endocrine.

[2]  A. Bracher,et al.  Chemogenomic Profiling of Human and Microbial FK506-Binding Proteins. , 2018, Journal of medicinal chemistry.

[3]  Mathias V. Schmidt,et al.  The stress regulator FKBP51: a novel and promising druggable target for the treatment of persistent pain states across sexes , 2018, Pain.

[4]  Hossein Mohammadiarani,et al.  Differential Protein Dynamics of Regulators of G-Protein Signaling: Role in Specificity of Small-Molecule Inhibitors. , 2018, Journal of the American Chemical Society.

[5]  M. Tschöp,et al.  Stress-responsive FKBP51 regulates AKT2-AS160 signaling and metabolic function , 2017, Nature Communications.

[6]  G. Klebe,et al.  Price for Opening the Transient Specificity Pocket in Human Aldose Reductase upon Ligand Binding: Structural, Thermodynamic, Kinetic, and Computational Analysis. , 2017, ACS chemical biology.

[7]  Hans Bitter,et al.  The allosteric inhibitor ABL001 enables dual targeting of BCR–ABL1 , 2017, Nature.

[8]  Weidong Yong,et al.  FKBP51 Null Mice Are Resistant to Diet-Induced Obesity and the PPARγ Agonist Rosiglitazone. , 2016, Endocrinology.

[9]  Jonathan C. Fuller,et al.  Protein Binding Pocket Dynamics. , 2016, Accounts of chemical research.

[10]  A. Bracher,et al.  Rapid, Structure-Based Exploration of Pipecolic Acid Amides as Novel Selective Antagonists of the FK506-Binding Protein 51. , 2016, Journal of medicinal chemistry.

[11]  C. Bell,et al.  The stress regulator FKBP51 drives chronic pain by modulating spinal glucocorticoid signaling , 2016, Science Translational Medicine.

[12]  S. Knapp,et al.  The ins and outs of selective kinase inhibitor development. , 2015, Nature chemical biology.

[13]  A. Bracher,et al.  Structure-Affinity Relationship Analysis of Selective FKBP51 Ligands. , 2015, Journal of medicinal chemistry.

[14]  A. Bracher,et al.  Rational design and asymmetric synthesis of potent and neurotrophic ligands for FK506-binding proteins (FKBPs). , 2015, Angewandte Chemie.

[15]  A. Bracher,et al.  Rationales Design und asymmetrische Synthese potenter neuritotropher Liganden für FK506‐bindende Proteine (FKBPs) , 2015 .

[16]  A. Bracher,et al.  Stereoselective construction of the 5-hydroxy diazabicyclo[4.3.1]decane-2-one scaffold, a privileged motif for FK506-binding proteins. , 2014, Organic letters.

[17]  Hak-Sung Kim,et al.  Protein conformational dynamics dictate the binding affinity for a ligand , 2014, Nature Communications.

[18]  A. Bracher,et al.  Increasing the efficiency of ligands for FK506-binding protein 51 by conformational control. , 2013, Journal of medicinal chemistry.

[19]  F. Holsboer,et al.  The Prospect of FKBP51 as a Drug Target , 2012, ChemMedChem.

[20]  A. Bracher,et al.  Exploration of pipecolate sulfonamides as binders of the FK506-binding proteins 51 and 52. , 2012, Journal of medicinal chemistry.

[21]  A. Bracher,et al.  Evaluation of synthetic FK506 analogues as ligands for the FK506-binding proteins 51 and 52. , 2012, Journal of medicinal chemistry.

[22]  F. Holsboer,et al.  The involvement of FK506-binding protein 51 (FKBP5) in the behavioral and neuroendocrine effects of chronic social defeat stress , 2012, Neuropharmacology.

[23]  Andrew L. Lee,et al.  Evidence for dynamics in proteins as a mechanism for ligand dissociation , 2011, Nature chemical biology.

[24]  F. Holsboer,et al.  FK506 Binding Protein 5 Shapes Stress Responsiveness: Modulation of Neuroendocrine Reactivity and Coping Behavior , 2011, Biological Psychiatry.

[25]  E. Weeber,et al.  A New Anti-Depressive Strategy for the Elderly: Ablation of FKBP5/FKBP51 , 2011, PloS one.

[26]  J. Scammell,et al.  Organization and function of the FKBP52 and FKBP51 genes. , 2011, Current opinion in pharmacology.

[27]  L. Kay,et al.  NMR spectroscopy brings invisible protein states into focus. , 2009, Nature chemical biology.

[28]  R. Nussinov,et al.  The role of dynamic conformational ensembles in biomolecular recognition. , 2009, Nature chemical biology.

[29]  L. Kay,et al.  Using relaxation dispersion NMR spectroscopy to determine structures of excited, invisible protein states , 2008, Journal of biomolecular NMR.

[30]  J Patrick Loria,et al.  Characterization of enzyme motions by solution NMR relaxation dispersion. , 2008, Accounts of chemical research.

[31]  V. Helms,et al.  Transient pockets on protein surfaces involved in protein-protein interaction. , 2007, Journal of medicinal chemistry.

[32]  A. Palmer,et al.  A Relaxation-Compensated Carr−Purcell−Meiboom−Gill Sequence for Characterizing Chemical Exchange by NMR Spectroscopy , 1999 .

[33]  R. Hodges,et al.  Relationship of sidechain hydrophobicity and α‐helical propensity on the stability of the single‐stranded amphipathic α‐helix , 1995 .

[34]  T. Pawson,et al.  Backbone dynamics of a free and phosphopeptide-complexed Src homology 2 domain studied by 15N NMR relaxation. , 1994, Biochemistry.

[35]  A. Bracher,et al.  Selective inhibitors of the FK506-binding protein 51 by induced fit. , 2015, Nature chemical biology.

[36]  A. Palmer,et al.  Solution NMR spin relaxation methods for characterizing chemical exchange in high-molecular-weight systems. , 2005, Methods in enzymology.